company background image
8VP1 logo

Avricore Health DB:8VP1 Stock Report

Last Price

€0.038

Market Cap

€4.4m

7D

-2.6%

1Y

-60.6%

Updated

21 Jan, 2025

Data

Company Financials

8VP1 Stock Overview

Engages in the health data and point-of-care technologies business in Canada. More details

8VP1 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Avricore Health Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Avricore Health
Historical stock prices
Current Share PriceCA$0.038
52 Week HighCA$0.20
52 Week LowCA$0.015
Beta-2.07
1 Month Change11.76%
3 Month Change-63.46%
1 Year Change-60.62%
3 Year Change-59.14%
5 Year Change660.00%
Change since IPO-97.05%

Recent News & Updates

Recent updates

Shareholder Returns

8VP1DE Healthcare ServicesDE Market
7D-2.6%1.1%3.0%
1Y-60.6%-23.4%13.2%

Return vs Industry: 8VP1 underperformed the German Healthcare Services industry which returned -22.2% over the past year.

Return vs Market: 8VP1 underperformed the German Market which returned 13.1% over the past year.

Price Volatility

Is 8VP1's price volatile compared to industry and market?
8VP1 volatility
8VP1 Average Weekly Movement27.0%
Healthcare Services Industry Average Movement6.5%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.8%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 8VP1's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 8VP1's weekly volatility has increased from 19% to 27% over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996n/aHector Bremneravricore.com

Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a turnkey point-of-care testing platform that turns pharmacies into community point-of-care diagnostic centers. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018.

Avricore Health Inc. Fundamentals Summary

How do Avricore Health's earnings and revenue compare to its market cap?
8VP1 fundamental statistics
Market cap€4.41m
Earnings (TTM)€69.05k
Revenue (TTM)€3.16m

63.8x

P/E Ratio

1.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8VP1 income statement (TTM)
RevenueCA$4.72m
Cost of RevenueCA$2.93m
Gross ProfitCA$1.79m
Other ExpensesCA$1.69m
EarningsCA$103.13k

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.001
Gross Margin37.97%
Net Profit Margin2.19%
Debt/Equity Ratio0%

How did 8VP1 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/21 20:58
End of Day Share Price 2025/01/21 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Avricore Health Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution